Jacqz-Aigrain E - Search Results

1

Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.

Tang BH, Zhang JY, Allegaert K, Hao GX, Yao BF, Leroux S, Thomson AH, Yu Z, Gao F, Zheng Y, Zhou Y, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Jacqz-Aigrain E, van den Anker J, Wu YE, Zhao W. Tang BH, et al. Among authors: jacqz aigrain e. Clin Pharmacokinet. 2023 Aug;62(8):1105-1116. doi: 10.1007/s40262-023-01265-z. Epub 2023 Jun 10. Clin Pharmacokinet. 2023. PMID: 37300630 Free article.

2

Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients.

Zhao W, Baudouin V, Zhang D, Deschênes G, Le Guellec C, Jacqz-Aigrain E. Zhao W, et al. Clin Pharmacokinet. 2009;48(5):321-8. doi: 10.2165/00003088-200948050-00004. Clin Pharmacokinet. 2009. PMID: 19566115 Clinical Trial.

3

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.

Zhao W, Fakhoury M, Deschênes G, Roussey G, Brochard K, Niaudet P, Tsimaratos M, André JL, Cloarec S, Cochat P, Bensman A, Azougagh S, Jacqz-Aigrain E. Zhao W, et al. J Clin Pharmacol. 2010 Nov;50(11):1280-91. doi: 10.1177/0091270009357429. Epub 2010 Feb 10. J Clin Pharmacol. 2010. PMID: 20147615 Clinical Trial.

4

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

Zhao W, Elie V, Baudouin V, Bensman A, André JL, Brochard K, Broux F, Cailliez M, Loirat C, Jacqz-Aigrain E. Zhao W, et al. Br J Clin Pharmacol. 2010 Apr;69(4):358-66. doi: 10.1111/j.1365-2125.2010.03615.x. Br J Clin Pharmacol. 2010. PMID: 20406220 Free PMC article. Clinical Trial.

5

Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: an adapted method for neonates.

Grondin C, Zhao W, Fakhoury M, Jacqz-Aigrain E. Grondin C, et al. Biomed Chromatogr. 2011 Jul;25(7):827-32. doi: 10.1002/bmc.1523. Epub 2010 Sep 27. Biomed Chromatogr. 2011. PMID: 20872911

6

Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.

Zhao W, Fakhoury M, Jacqz-Aigrain E. Zhao W, et al. Ther Drug Monit. 2010 Dec;32(6):688-99. doi: 10.1097/FTD.0b013e3181f6502d. Ther Drug Monit. 2010. PMID: 21068645 Review.

7

Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

Cella M, Zhao W, Jacqz-Aigrain E, Burger D, Danhof M, Della Pasqua O. Cella M, et al. Br J Clin Pharmacol. 2011 Sep;72(3):454-64. doi: 10.1111/j.1365-2125.2011.03992.x. Br J Clin Pharmacol. 2011. PMID: 21501213 Free PMC article.

8

Principles of therapeutic drug monitoring.

Zhao W, Jacqz-Aigrain E. Zhao W, et al. Handb Exp Pharmacol. 2011;205:77-90. doi: 10.1007/978-3-642-20195-0_3. Handb Exp Pharmacol. 2011. PMID: 21882106

9

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.

Zhao W, Fakhoury M, Baudouin V, Maisin A, Deschênes G, Jacqz-Aigrain E. Zhao W, et al. Ther Drug Monit. 2011 Dec;33(6):681-7. doi: 10.1097/FTD.0b013e318235d067. Ther Drug Monit. 2011. PMID: 22011724 Clinical Trial.

10

Individualization of valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant patients.

Zhao W, Fakhoury M, Fila M, Baudouin V, Deschênes G, Jacqz-Aigrain E. Zhao W, et al. Ther Drug Monit. 2012 Jun;34(3):326-30. doi: 10.1097/FTD.0b013e3182509e3a. Ther Drug Monit. 2012. PMID: 22495424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters